Table 3 Presence of serum IgG antibodies specific for KU‐MEL‐1 and other related antigens in VKH patients and healthy individuals†.
| Antigen | VKH | Healthy individuals |
|---|---|---|
| Positive/total (%) | Positive/total (%) | |
| KU‐MEL‐1 | 22/35 (63%)* | 2/52 (4%) |
| Tyrosinase | 0/20 (0%) | 0/22 (0%) |
| NY‐ESO‐1 | 0/26 (0%) | 0/22 (0%) |
| LEDGF | 4/12 (33%) | 3/6 (50%) |
†Presence of IgG specific for each antigen was evaluated by the method similar to that the cDNA library screening with sera at 1:100 dilution.
*p<0.01 (v healthy donor by Fisher's exact probability test).